Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway

• المؤلفون الرئيسيون: Arora, Loukik, Mohan, Chakrabhavi Dhananjaya, Yang, Min Hee, Rangappa, Shobith, Deivasigamani, Amudha, Kumar, Alan Prem, Kunnumakkara, Ajaikumar B., Garg, Manoj, Chinnathambi, Arunachalam, Alharbi, Sulaiman Ali, Alahmadi, Tahani Awad, Rangappa, Kanchugarakoppal S., Hui, Kam Man, Sethi, Gautam, Ahn, Kwang Seok
• مؤلفون آخرون: PHARMACOLOGY
• التنسيق: مقال
• منشور في: MDPI 2022
• الموضوعات: Orthotopic; SHP2; STAT3 signaling inhibitor; Tris DBA; Xenograft
• الوصول للمادة أونلاين: https://scholarbank.nus.edu.sg/handle/10635/232792

10.3390/cancers13215479